Global Influenza (Flu) Antiviral Drugs Market Growth (Status and Outlook) 2020-2025

Global Influenza (Flu) Antiviral Drugs Market Growth (Status and Outlook) 2020-2025

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

According to this latest study, the 2020 growth of Influenza (Flu) Antiviral Drugs will have significant change from previous year. By the most conservative estimates of global Influenza (Flu) Antiviral Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Influenza (Flu) Antiviral Drugs market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Influenza (Flu) Antiviral Drugs market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Influenza (Flu) Antiviral Drugs, covering the supply chain analysis, impact assessment to the Influenza (Flu) Antiviral Drugs market size growth rate in several scenarios, and the measures to be undertaken by Influenza (Flu) Antiviral Drugs companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Penetration and Dehulling Inhibitors
DNA Polymerase Inhibitors
Reverse Transcriptase Inhibitors
Protein Inhibitors
Neuraminidase Inhibitors
Broad-spectrum Antiviral Drugs

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Hospital
Clinic
Household
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Amgen
Roche
Johnson & Johnson
Merck & Co. (MSD)
Sanofi
Gilead Sciences
Novartis
GlaxoSmithKline (GSK)
AbbVie
Novo Nordisk
Takeda
Allergan
AstraZeneca
Teva
Eli Lilly
Bayer
Bristol-Myers Squibb
Boehringer Ingelheim

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Influenza (Flu) Antiviral Drugs market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Influenza (Flu) Antiviral Drugs market by identifying its various subsegments.
Focuses on the key global Influenza (Flu) Antiviral Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Influenza (Flu) Antiviral Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Influenza (Flu) Antiviral Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Please note: The report will take approximately 2 business days to prepare and deliver.


1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
1.7 What is the Impact of Covid-19 Outbreak On the Influenza (Flu) Antiviral Drugs?
1.7.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.7.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.7.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Influenza (Flu) Antiviral Drugs Market Size in 2020, by Scenario
1.7.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Influenza (Flu) Antiviral Drugs Market Size 2015-2025
2.1.2 Influenza (Flu) Antiviral Drugs Market Size CAGR by Region
2.2 Influenza (Flu) Antiviral Drugs Segment by Type
2.2.1 Penetration and Dehulling Inhibitors
2.2.2 Penetration and Dehulling Inhibitors
2.2.3 Reverse Transcriptase Inhibitors
2.2.4 Protein Inhibitors
2.2.5 Neuraminidase Inhibitors
2.2.6 Broad-spectrum Antiviral Drugs
2.3 Influenza (Flu) Antiviral Drugs Market Size by Type
2.3.1 Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Type (2015-2020)
2.3.2 Global Influenza (Flu) Antiviral Drugs Market Size Growth Rate by Type (2015-2020)
2.4 Influenza (Flu) Antiviral Drugs Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Household
2.4.4 Others
2.5 Influenza (Flu) Antiviral Drugs Market Size by Application
2.5.1 Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Application (2015-2020)
2.5.2 Global Influenza (Flu) Antiviral Drugs Market Size Growth Rate by Application (2015-2020)
3 Global Influenza (Flu) Antiviral Drugs by Players
3.1 Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Players
3.1.1 Global Influenza (Flu) Antiviral Drugs Market Size by Players (2018-2020)
3.1.2 Global Influenza (Flu) Antiviral Drugs Market Size Market Share by Players (2018-2020)
3.2 Global Influenza (Flu) Antiviral Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Influenza (Flu) Antiviral Drugs by Regions
4.1 Influenza (Flu) Antiviral Drugs Market Size by Regions
4.2 Americas Influenza (Flu) Antiviral Drugs Market Size Growth
4.3 APAC Influenza (Flu) Antiviral Drugs Market Size Growth
4.4 Europe Influenza (Flu) Antiviral Drugs Market Size Growth
4.5 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size Growth
5 Americas
5.1 Americas Influenza (Flu) Antiviral Drugs Market Size by Countries
5.2 Americas Influenza (Flu) Antiviral Drugs Market Size by Type
5.3 Americas Influenza (Flu) Antiviral Drugs Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Influenza (Flu) Antiviral Drugs Market Size by Regions
6.2 APAC Influenza (Flu) Antiviral Drugs Market Size by Type
6.3 APAC Influenza (Flu) Antiviral Drugs Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Influenza (Flu) Antiviral Drugs by Countries
7.2 Europe Influenza (Flu) Antiviral Drugs Market Size by Type
7.3 Europe Influenza (Flu) Antiviral Drugs Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Influenza (Flu) Antiviral Drugs by Countries
8.2 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Type
8.3 Middle East & Africa Influenza (Flu) Antiviral Drugs Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Influenza (Flu) Antiviral Drugs Market Forecast
10.1 Global Influenza (Flu) Antiviral Drugs Market Size Forecast (2021-2025)
10.2 Global Influenza (Flu) Antiviral Drugs Forecast by Regions
10.2.1 Global Influenza (Flu) Antiviral Drugs Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Influenza (Flu) Antiviral Drugs Forecast by Type
10.8 Global Influenza (Flu) Antiviral Drugs Forecast by Application
11 Key Players Analysis
11.1 Pfizer
11.1.1 Company Details
11.1.2 Influenza (Flu) Antiviral Drugs Product Offered
11.1.3 Pfizer Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Pfizer News
11.2 Amgen
11.2.1 Company Details
11.2.2 Influenza (Flu) Antiviral Drugs Product Offered
11.2.3 Amgen Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Amgen News
11.3 Roche
11.3.1 Company Details
11.3.2 Influenza (Flu) Antiviral Drugs Product Offered
11.3.3 Roche Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Roche News
11.4 Johnson & Johnson
11.4.1 Company Details
11.4.2 Influenza (Flu) Antiviral Drugs Product Offered
11.4.3 Johnson & Johnson Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Johnson & Johnson News
11.5 Merck & Co. (MSD)
11.5.1 Company Details
11.5.2 Influenza (Flu) Antiviral Drugs Product Offered
11.5.3 Merck & Co. (MSD) Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Merck & Co. (MSD) News
11.6 Sanofi
11.6.1 Company Details
11.6.2 Influenza (Flu) Antiviral Drugs Product Offered
11.6.3 Sanofi Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Sanofi News
11.7 Gilead Sciences
11.7.1 Company Details
11.7.2 Influenza (Flu) Antiviral Drugs Product Offered
11.7.3 Gilead Sciences Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Gilead Sciences News
11.8 Novartis
11.8.1 Company Details
11.8.2 Influenza (Flu) Antiviral Drugs Product Offered
11.8.3 Novartis Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Novartis News
11.9 GlaxoSmithKline (GSK)
11.9.1 Company Details
11.9.2 Influenza (Flu) Antiviral Drugs Product Offered
11.9.3 GlaxoSmithKline (GSK) Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 GlaxoSmithKline (GSK) News
11.10 AbbVie
11.10.1 Company Details
11.10.2 Influenza (Flu) Antiviral Drugs Product Offered
11.10.3 AbbVie Influenza (Flu) Antiviral Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 AbbVie News
11.11 Novo Nordisk
11.12 Takeda
11.13 Allergan
11.14 AstraZeneca
11.15 Teva
11.16 Eli Lilly
11.17 Bayer
11.18 Bristol-Myers Squibb
11.19 Boehringer Ingelheim
12 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook